✦ LIBER ✦

Debrisoquine oxidative phenotyping and psychiatric drug treatment

✍ Scribed by F. Derenne; C. Joanne; S. Vandel; G. Bertschy; R. Volmat; P. Bechtel

Book ID: 104810478
Publisher: Springer
Year: 1989
Tongue: English
Weight: 508 KB
Volume: 36
Category: Article
ISSN: 0031-6970
DOI: 10.1007/bf00561023

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lack of relationship between tolbutamide

Lack of relationship between tolbutamide metabolism and debrisoquine oxidation phenotype

✍ G. F. Peart; J. Boutagy; G. M. Shenfield 📂 Article 📅 1987 🏛 Springer 🌐 English ⚖ 644 KB

Debrisoquine oxidation phenotype and sus

Debrisoquine oxidation phenotype and susceptibility to lung cancer [letter; comment]

✍ AR Boobis; DS Davies 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 569 KB

Pharmaco-metabonomic phenotyping and per

Pharmaco-metabonomic phenotyping and personalized drug treatment

✍ Andrew Clayton, T.; Lindon, John C.; Cloarec, Olivier; Antti, Henrik; Charuel, C 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 357 KB

The relationship between debrisoquine ox

The relationship between debrisoquine oxidation phenotype and the pharmacokinetics of chlorpropamide

✍ J. Kallio; R. Huupponen; K. Pyykkö 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 267 KB

Metabolism of paracetamol and phenacetin

Metabolism of paracetamol and phenacetin in relation to debrisoquine oxidation phenotype

✍ M. E. Veronese; S. McLean 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 714 KB

The metabolism of paracetamol and phenacetin has been studied in subjects previously phenotyped as either extensive or poor metabolisers of debrisoquine (EM and PM, respectively), in order to examine the relationship between phenacetin and paracetamol activation and debrisoquine oxidation status. In

Psychiatric Syndromes and Drug Treatment

✍ Ananth, J. 📂 Article 📅 1981 🏛 American Psychiatric Publishing Inc 🌐 English ⚖ 244 KB